Coloplast A/S (OTCMKTS:CLPBY) Short Interest Up 26.9% in February

Coloplast A/S (OTCMKTS:CLPBY) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 77,000 shares, a growth of 26.9% from the February 13th total of 60,700 shares. Based on an average daily trading volume, of 268,300 shares, the days-to-cover ratio is presently 0.3 days.

Coloplast A/S Trading Up 0.7 %

Shares of OTCMKTS:CLPBY opened at $10.54 on Monday. The firm’s 50 day moving average price is $11.07 and its 200-day moving average price is $12.10. Coloplast A/S has a twelve month low of $10.43 and a twelve month high of $14.14. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. Research analysts predict that Coloplast A/S will post 0.31 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently commented on CLPBY shares. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 11th. Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research report on Monday, November 18th. Sanford C. Bernstein raised shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Finally, Royal Bank of Canada raised shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.